Prescription Drugs: Medicare - Kaiser Family Foundation

Sort Documents by:

Document Type:

Date Range:

Prescription Drugs: Medicare

Estimates of Medicare Beneficiaries' Out-of-Pocket Drug Spending in 2006
This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006.

Resources on the Medicare Prescription Drug Benefit
A collection of reports, fact sheets, surveys, and other research and background material on the Medicare program's new drug benefit and other provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.

Recent Documents: (153 results)

Pages 1 | 2 | 3 | 4 | 5 >>

Medicare Part D 2008 Data Spotlight: Ten Most Common Brand-Name Drugs -- April 2008
This Medicare Part D Data Spotlight examines the variation in coverage, cost sharing and utilization management tools for the 10 prescriptions most commonly used by Medicare beneficiaries, including treatments for cholesterol, cardiovascular health, osteoporosis, dementia, gastrointestinal reflux and ulcers.

Medicare Part D 2008 Data Spotlight: Low-Income Subsidy Plan Availability -- April 2008
This Medicare Part D Data Spotlight focuses on the availability of drug plans for beneficiaries receiving the Part D low-income subsidy in 2008 and changes since 2006.

Medicare Prescription Drug Plans in 2008 and Key Changes Since 2006: Summary of Findings -- April 2008
This synthesis of key findings from analysis presented in a series of eight Medicare Part D 2008 Data Spotlights describes key features of stand-alone prescription drug plans offered in 2008 and trends since 2006.

Low-Income Assistance Under the Medicare Drug Benefit -- February 2008
This fact sheet provides an overview of the Medicare drug benefit and the additional subsidies available to certain eligible low-income beneficiaries.

The Medicare Prescription Drug Benefit - An Updated Fact Sheet -- February 2008
This updated fact sheet includes the latest information and data about the Medicare Drug Benefit, including a breakdown of the standard benefit, updates on additional low-income assistance, and the latest 2007 enrollment data.

Methodology Appendix to the Medicare Part D 2008 Data Spotlights -- January 2008
The Kaiser Family Foundation has also posted an appendix detailing the methodology used in the Medicare Part D 2008 Data Spotlight series. The series analyzes key aspects of the 2008 Medicare Part D prescription drug plan choices.

Medicare Part D 2008 Data Spotlight: Formularies -- January 2008
This spotlight examines the formularies (list of covered drugs) of Medicare stand-alone prescription drug plans in 2008, changes since 2006, and differences in how plans cover brand-name and generic drugs. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices.

Medicare Part D 2008 Data Spotlight: Utilization Management -- January 2008
This spotlight examines three common techniques used by stand-alone prescription drug plans to manage enrollees’ use of formulary drugs, such as quantity limits, prior authorization, and step therapy rules. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices.

Financing Medicare: An Issue Brief -- January 2008
This issue brief provides an overview of Medicare's financing and the fiscal challenges the program faces in the coming decades and examines several methods of assessing its long-term financial outlook.

Medicare Part D 2008 Data Spotlight: Premiums -- November 2007
This data spotlight analyzes the premiums charged by the 1,824 stand-alone Medicare Part D plans that will be offered in markets across the country in 2008 and how they have changed over time.

This Medicare Part D Data Spotlight examines the variation in coverage, cost sharing and utilization management tools for the 10 prescriptions most commonly used by Medicare beneficiaries, including treatments for cholesterol, cardiovascular health, osteoporosis, dementia, gastrointestinal reflux and ulcers.

This Medicare Part D Data Spotlight focuses on the availability of drug plans for beneficiaries receiving the Part D low-income subsidy in 2008 and changes since 2006.

This synthesis of key findings from analysis presented in a series of eight Medicare Part D 2008 Data Spotlights describes key features of stand-alone prescription drug plans offered in 2008 and trends since 2006.

This fact sheet provides an overview of the Medicare drug benefit and the additional subsidies available to certain eligible low-income beneficiaries.

This updated fact sheet includes the latest information and data about the Medicare Drug Benefit, including a breakdown of the standard benefit, updates on additional low-income assistance, and the latest 2007 enrollment data.

The Kaiser Family Foundation has also posted an appendix detailing the methodology used in the Medicare Part D 2008 Data Spotlight series. The series analyzes key aspects of the 2008 Medicare Part D prescription drug plan choices.

This spotlight examines the formularies (list of covered drugs) of Medicare stand-alone prescription drug plans in 2008, changes since 2006, and differences in how plans cover brand-name and generic drugs. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices.

This spotlight examines three common techniques used by stand-alone prescription drug plans to manage enrollees’ use of formulary drugs, such as quantity limits, prior authorization, and step therapy rules. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices.

This issue brief provides an overview of Medicare's financing and the fiscal challenges the program faces in the coming decades and examines several methods of assessing its long-term financial outlook.

This data spotlight analyzes the premiums charged by the 1,824 stand-alone Medicare Part D plans that will be offered in markets across the country in 2008 and how they have changed over time.

View all items >

Pages 1 | 2 | 3 | 4 | 5 >>

Prescription Drugs: Medicare

Prescription drug use increases with age along with the prevalence of chronic and acute health problems. However, because Medicare does not cover outpatient prescription drugs, 38% of seniors and younger beneficiaries with disabilities had no drug coverage in the Fall of 1999. Rising drug costs pose challenges for Medicare beneficiaries, who tend to use more medications (averaging 23 per year in 1999) than do younger adults. The Congressional Budget Office projects that total drug spending for the Medicare population will grow from $95 billion in 2003 to $284 billion in 2013, increasing at an average annual rate of over 10% and totaling $1.8 trillion (2004-2013).